Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
86,510 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| May 17, 2026 | BCBS Oklahoma | Tests for Amniotic Protein to Detect Rupture of Membranes (ROM) in Pregnancy | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Anifrolumab-fnia (Saphnelo) | Criteria changed |
| May 17, 2026 | BCBS Oklahoma | Testosterone Replacement Therapies | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Angioplasty or Stenting for Intracranial Arterial Disease (Atherosclerosis and Aneurysms) | Criteria changed |
| May 17, 2026 | BCBS Oklahoma | Teprotumumab-trbw | Criteria changed |
| May 17, 2026 | BCBS Oklahoma | Teplizumab-mzwv | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Intravenous Anesthetics for the Treatment of Chronic Pain and Psychiatric Disorders | Criteria changed |
| May 17, 2026 | BCBS Oklahoma | Temporomandibular Joint Disorders | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Vutrisiran (Amvuttra) | Criteria changed |
| May 17, 2026 | BCBS Oklahoma | Temporarily Implanted Nitinol Device (iTind) for Benign Prostatic Hyperplasia | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Lifileucel (Amtagvi) | Criteria changed |
| May 17, 2026 | BCBS Oklahoma | Sutimlimab-jome | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Cytochrome p450 Genotyping | Criteria changed |
| May 17, 2026 | BCBS Oklahoma | Surgical Ventricular Restoration | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Casimersen (Amondys 45) | Criteria changed |
| May 17, 2026 | BCBS Oklahoma | Surgical Treatments for Breast Cancer-Related Lymphedema | Criteria changed |
| May 17, 2026 | BCBS Oklahoma | Surgical Treatment of Gynecomastia | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Human Amniotic Membrane Grafts and Amniotic Fluid Injections | Criteria changed |
| May 17, 2026 | BCBS Oklahoma | Surgical Treatment of Femoroacetabular Impingement | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Amivantamab-vmjw (Rybrevant) | Criteria changed |
| May 17, 2026 | BCBS Oklahoma | Surgical Left Atrial Appendage Occlusion Devices for Stroke Prevention in Atrial Fibrillation | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Complementary and Alternative Medicine | Criteria changed |
| May 17, 2026 | BCBS Oklahoma | Surgical Deactivation of Headache Trigger Sites | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Alpha-1 Proteinase Inhibitor (Aralast NP, Glassia, Prolastin-C, Zemaira) | Criteria changed |
| May 17, 2026 | BCBS Oklahoma | Surgery for Groin Pain in Athletes | Criteria changed |
| May 17, 2026 | BCBS Oklahoma | Surface Electromyography and Paraspinal Surface Electromyography to Evaluate and Monitor Back Pain | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Osteochondral Allografting | Criteria changed |
| May 17, 2026 | BCBS Oklahoma | Surface Electrical Stimulation | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Meniscal Allografts and Synthetic Meniscus Implants | Criteria changed |
| May 17, 2026 | BCBS Oklahoma | Subtalar Arthroereisis | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Allogeneic Processed Thymus Tissue-agdc (Rethymic) | Criteria changed |
| May 17, 2026 | BCBS Oklahoma | Sublingual Immunotherapy as a Technique of Allergen-Specific Therapy | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Bioengineered Skin and Soft Tissue Substitutes | Criteria changed |
| May 17, 2026 | BCBS Oklahoma | Stem Cell Therapy for Peripheral Arterial Disease | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Allergy Testing - Leukocyte Histamine Release Test (LHRT) | Criteria changed |
| May 17, 2026 | BCBS Oklahoma | Stationary Ultrasonic Diathermy Devices | Criteria changed |
| May 17, 2026 | BCBS Oklahoma | Spinal Cord Stimulation (SCS) and Dorsal Root Ganglion (DRG) Stimulation | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Conjunctival Challenge Test | Criteria changed |
| May 17, 2026 | BCBS Oklahoma | Sphenopalatine Ganglion Block for Headache | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Alglucosidase Alfa (Lumizyme) | Criteria changed |
| May 17, 2026 | BCBS Oklahoma | Spesolimab-sbzo | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Alemtuzumab (Lemtrada) | Criteria changed |
| May 17, 2026 | BCBS Oklahoma | Speech-Language Therapy (SLT) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Laronidase (Aldurazyme) | Criteria changed |
| May 17, 2026 | BCBS Oklahoma | Speech Generating Devices (SGD) | Criteria changed |
| May 17, 2026 | BCBS Oklahoma | Specialty Medication Administration Site of Care | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Aldesleukin IL‐2 (Proleukin) | Criteria changed |
| May 17, 2026 | BCBS Oklahoma | Small Bowel/Liver and Multivisceral Transplant | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Agalsidase Beta(Fabrazyme) | Criteria changed |
| May 17, 2026 | BCBS Oklahoma | Sleep Related Breathing Disorders: Surgical Management | Criteria changed |